Pertuzumab's impact on cervical cancer treatment has been the focus of several recent research. Combining this monoclonal antibody with additional treatment drugs has demonstrated promise in enhancing the immune response and shrinking tumour size. Inhibiting HER2 receptor dimerisation is the main mechanism of action of pertuzumab. This is important since unchecked cell proliferation is a hallmark of many cancer types, including cervical cancer.
From a physiological point of view, pertuzumab specifically affects the cell cycle and DNA repair capabilities of cancer cells. Along with halting tumour growth, blocking these chemical pathways makes the cells more vulnerable to other therapies like radiation and chemotherapy. Using medications like Zantac eff pill 25 mg together may
